Search Results 1561-1570 of 21900 for Inhibition
Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM) Rochester, MN. The purpose of this study is to test whether abatacept, as compared to placebo, ...
Subject is using pramlintide (Symlin), SGLT2 inhibitors, GLP agonists, biguanides, DPP-4 inhibitors or sulfonylureas more than 2 weeks from time of screening.
Reishi Mushroom for Fatigue And/or Arthralgias for Patients With Breast Cancer on Aromatase Inhibitors ... inhibitor toxicities, specifically fatigue, and ...
... inhibitors including baricitinib, TNF inhibitors, or interferon within 4 weeks or 5 half-lives prior to screening. Steroid dependency defined as need for ...
... inhibitor therapy. It is acceptable to omit the first dose of PD-L1 inhibitor therapy due to logistical reasons if receiving SoC during or prior to the ...
... inhibitor. Wait for 2 weeks after stopping bupropion before you start taking a MAO inhibitor. If you take them together or do not wait 2 weeks, you may have ...
... inhibitor, EGFR inhibitor), endocrine therapy, or radiation therapy; Patients is receiving adjuvant treatment for non-metastatic (Stage I-III) cancer and has ...
Use of calcineurin inhibitors or purine analogues, or potent cytochrome P450 (CYP) 3A4 inhibitors in the 12 weeks prior to Screening;; Have a ...
Complement system inhibitors (e.g., eculizumab). 3. Proteasome inhibitors (e.g., bortezomib). 4. Tocilizumab. 5. Any other investigational agent within 3 ...
Use of the following strong or moderate inhibitors are prohibited < 7 days prior to registration; Receiving any medications or substances that are inducers ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!